Serial Number | 98451137 |
Word Mark | HYLACROSS |
Filing Date | Friday, March 15, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Wednesday, April 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | pharmaceutical preparations to treat dermatological conditions; medical preparations consisting of a dermatological preparation, individually or in a set, including, but not exclusively, pre-filled syringes, for filling lines, wrinkles, lips, for tightening the face and body and for rejuvenating the skin; medicinal preparations for the treatment of dermatological conditions; injectable pharmaceutical products to treat dermatological conditions; injectable dermal fillers; pharmaceutical preparations for skin care |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 15, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Friday, September 1, 2006 |
First Use In Commerce Date | Friday, September 1, 2006 |
Party Name | Allergan, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | North Chicago, IL 60050 |
Event Date | Event Description |
Monday, March 18, 2024 | NEW APPLICATION ENTERED |
Tuesday, April 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, April 23, 2024 | ASSIGNED TO EXAMINER |
Wednesday, April 24, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, April 24, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, April 24, 2024 | NON-FINAL ACTION E-MAILED |
Friday, April 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |